source
- Cadence raises $100M Series C to advance clinical AI for autonomous medical careCadence, a health tech startup, announced a $100 million Series C financing round aimed at expanding its artificial intelligence platform. The new capital will support development of AI tools that…
- Roche’s divarasib shows survival benefit over Amgen and BMS drugs in KRAS G12C lung cancer trialRoche reported that its experimental KRAS G12C inhibitor divarasib extended overall survival and progression‑free survival in a Phase 3 head‑to‑head study against Amgen’s Lumakra and Bristol Myers…